Peptide Supplier Qualification txhais tau li cas hauv 2026
Peptide tus neeg tsim khoom tsim nyog yog cov ntaub ntawv txheej txheem ntawm kev tsim, ua ntej koj yuav, uas tus neeg muag khoom tuaj yeem ua pov thawj tias nws yog leej twg, nws ua dab tsi, cov khoom mus qhov twg, thiab yuav ua li cas nws yuav tsiv hla ciam teb. Hauv 2026 Qhov kev txhais ntawd tseem ceeb tsawg dua li cov kauj ruam yuav khoom thiab ntau dua li qhov kev pab cuam pov thawj: ib cov ntaub ntawv koj tsim, tswj, thiab rov xyuas dua tsis yog lub thawv koj zuam ib zaug.
Txoj cai tswjfwm rov qab piav qhia vim li cas qhov kev hloov pauv. FDA tus nqi siv yog ib qho nyiaj txiag-thiab-txhim kho lub sijhawm, tsis yog tus qauv zoo: lawv them rau kev tshuaj xyuas lub peev xwm thiab lub sijhawm ua haujlwm uas cov tuam txhab tsim khoom, cov neeg muab khoom, thiab cov koom haum cog lus nyob ntawm (FDA cov kev pab cuam them nqi, 2026). FY2026 tus nqi them xyoo khiav 2025-10-01 rau 2026-09-30, thiab tag nrho plaub tus neeg siv tus nqi them nqi yuav tas rau lub Cuaj Hlis 30, 2027 tas sij hawm ntawm tag nrho plaub txoj cai (Holland & Knight, 2026-03). Hla txhua txheej uas ua raws li, txoj kab dhau los yog pov thawj, tsis them nyiaj.
Kev tsim nyog tsis yog daim ntawv pov thawj ntawm kev tshuaj xyuas, tsis yog tus nqi sib piv, thiab tsis yog ib zaug onboarding kauj ruam. Nws yog cov ntaub ntawv sawv cev uas teb rau tus tswj hwm, tus kws tshuaj xyuas, los yog koj tus kheej pab neeg zoo thaum lawv nug tib lo lus nug uas cov nqi them tsis tau: ua pov thawj.
Yog vim li cas lub nra ntawm pov thawj hloov
Peb lub zog nruj peptide qhov chaw ntawm lub Kaum Ob Hlis 2025 thiab Lub Ib Hlis 2026, thiab lawv tsis yog tib hom kev quab yuam. Ib tug yog enacted txoj cai, ib tug yog daim nqi uas tsis dhau, thiab ib qho yog ib qho xwm txheej txuas nrog tsoomfwv cov nyiaj. Kev kho lawv li ib nthwv dej yog qhov yuam kev tshaj plaws hauv kev tshuaj xyuas cov neeg muag khoom tam sim no.
Txoj Cai BIOSECURE tau tsim tawm hauv FY2026 National Defense Authorization Act, kos npe 2025-12-18 (BIOSECURE Act's Senate bill record, S., 3469). Qhov kev lees paub tam sim no nyob ntawm ib qho kev nyeem thawj zaug, yog li xyuas nws tawm tsam cov ntawv sau npe NDAA ua ntej koj hais nws hauv cov ntaub ntawv tsim nyog.
Cais, S., 3741, Biosecurity Modernization thiab Innovation Act ntawm 2026, tau qhia 2026-01-29 thiab xa mus rau Kev Lag Luam. Tsis yog txoj cai (nqe lus ntawm S.3741).
Qhov thib peb quab yuam yog technical. Hauv qab OSTP/NSTC Framework, qhov kev tshuaj ntsuam qhov rai nqaim los ntawm 200 nucleotides rau 50 nucleotides siv tau rau lub Kaum Hlis 13, 2026, thiab cov kws kho mob yuav tsum tshuaj xyuas txhua lub qhov rais 50-nucleotide rau qhov kev txhawj xeeb (ib tug phooj ywg-saib xyuas ntawm US nucleic-acid soj ntsuam txoj cai). This is what makes biosecurity screening for peptide suppliers a documentation question, not a policy one.
⚠️ Ceeb toom: Distinguish what is law (enacted NDAA provisions), what is proposed (S., 3741, not enacted), and what is a funding condition (the screening Framework attaching to federally funded research and federal procurement). A supplier that conflates the three is telling you something about its compliance literacy.
FDA Tus Neeg Siv Tus Nqi Them: Nws Ua Dab Tsi thiab Tsis Ua Pov Thawj
Kev pabcuam User fees buy review capacity and predictable timelines. They do not certify that a peptide is pure, sterile, correctly sequenced, or fit for your process. That distinction matters because fee standing is the easiest supplier attribute to verify and the least informative about material quality.
The FY2026 rates show the scale of that engagement. Under GDUFA III’s FY2026 facility-fee schedule, an ANDA filing fee runs $358,247 thiab tus nqi ntawm cov ntaub ntawv tshuaj $102,584, thaum FY2026 GDUFA tus neeg thov kev pab cuam-tus nqi tiers them cov neeg thov loj $1,918,377, nruab nrab $767,351 thiab me me $191,838. Tus nqi API qhov chaw yog $43,549 domestic thiab $58,549 txawv teb chaws, tom kawg reflecting tus cai txawv teb chaws-chaw hwm hwm ntawm $15,000.
|
Program |
FY 2026 tus nqi |
Sau ntawv |
|---|---|---|
|
PDUFA |
$4,682,003 |
Daim ntawv thov nrog cov ntaub ntawv kho mob |
|
GDUFA |
$358,247 |
Koj ua ntaub ntawv thov; DMF $102,584 |
|
BsUFA |
$1,200,794 |
Daim ntawv thov nrog cov ntaub ntawv kho mob |
|
MDUFA |
Peptide Synthesis $26,067 |
510(k); sau npe $11,423, nce mus $13,785 hauv FY 2027 |
Qhov chaw: FDA tau tshaj tawm FY2026 PDUFA tus nqi nqi, Lub sijhawm FY2026 BsUFA tus nqi them, thiab MDUFA's FY2026 tus nqi rooj.
Tag nrho plaub txoj cai yuav tas sijhawm 30 Cuaj hlis 2027, nrog kev sib tham pom zoo vim los ntawm HHS Tus Tuav Ntaub Ntawv los ntawm 15 Lub Ib Hlis 2027, raws li ib qho kev tswj xyuas ntawm cov 2027 daim ntawv qhia hnub siv tus nqi them rov qab. PDUFA VIII pre-negotiation proposal nqa ib lub vas $48.3 lab lub hauv paus-cov nyiaj tau los txo, nrog rau lub rooj sib tham pej xeem ntawm 16 Cuaj hlis 2026 thiab cov lus kaw 16 Kaum Hli 2026, raws li Tsoom Fwv Teb Chaws Register ceeb toom qhib PDUFA VIII cov lus pom.
Kho tus nqi sawv raws li tus neeg sawv cev rau kev tswj hwm kev koom tes, yeej tsis ua pov thawj ntawm peptide khoom tsim nyog.
Kev tshuaj ntsuam xyuas biosecurity: Dab tsi cov neeg muab khoom yuav raug nug kom ua pov thawj
Kev tshuaj xyuas biosecurity rau cov neeg muab khoom peptide yog txheej txheem kev tshuaj ntsuam xyuas, tsis yog nrhiav database. Nyob rau hauv lub moj khaum qhov kev txiav txim-kev tshuaj ntsuam mechanism, tus neeg muag khoom tshuaj xyuas txhua qhov kev txiav txim ntawm lub qhov rais ntev ntev tiv thaiv cov npe khaws cia ntawm cov kev txhawj xeeb, tom qab ntawd nug seb qhov luv luv lossis rov xaj los ntawm tib tus neeg siv khoom tuaj yeem sib sau ua ke ntev dua ntawm kev txhawj xeeb, txheeb xyuas cov neeg siv khoom raug cai rau kev txiav txim chij, qhia txog tej kev txiav txim tsis raug cai, khaws cov ntaub ntawv, thiab tiv thaiv kev tshuaj ntsuam xyuas thiab xaj cov ntaub ntawv. Cov ntsiab lus kawg yog vim li cas cov ntaub ntawv kev ruaj ntseg nyob hauv qhov kev tshuaj ntsuam xyuas ua haujlwm ntau dua li ntawm nws.
Daim ntawv sau nqi ntawm S.3741 yuav ua kom cov kauj ruam qhia meej txog kev lav ris: txheeb xyuas tus neeg siv khoom tus kheej thiab raug cai, npo txhua qhov kev txiav txim, txhawb nqa kev ceev ntiag tug-preserving submission mechanism uas pom cov kev txiav txim sib cais hla cov chaw muab kev pabcuam, tswj cov npe, kev sib koom tes ntawm cov koom haum, nrog cov kev cai yuav tsum tau them nyob rau hauv ib xyoos ntawm enactation. Executive Order 14292's directive to revised the screening Framework, tso May 5, 2025, muab OSTP 90 hnub los kho lossis hloov lub 2024 Lub moj khaum thiab taw qhia tseemfwv qib siab nyiaj txiag txoj sia-science procurement los ntawm cov chaw muab kev pabcuam. Cov ntawv txiav txim tsis muaj cov lus pov thawj ntawm cov neeg siv khoom, tsis muaj nucleotide pib, thiab tsis muaj Kaum Hli 13, 2026 hnub, qhov txawv ntau ntawm cov kev pab cuam tam sim no blurs.
False positives nqa tus nqi tiag. Tshaj tawm kev tshuaj ntsuam tsis tseeb-zoo thiab tus chij tus nqi suav a 2022 kev soj ntsuam raws li kwv yees ntau tshaj 4% Cov lus tsis tseeb ntawm IGSC cov tuam txhab koom nrog, ua phem rau cov ntu luv, thiab a 2024 kwv yees tias kwv yees 5% ntawm synthetic DNA txiav txim yog flagged, txhua lub sijhawm siv sijhawm los tshuaj xyuas. A 2025 NIST-dataset inter-tool ntsuam xyuas cov ntaub ntawv saum toj no 95% rhiab heev thiab 97% qhov tseeb. Tsis muaj ib qho ntawm cov nuj nqis no yog peptide tshwj xeeb; txhua yam piav qhia txog kev tshuaj ntsuam nucleic-acid synthesis, thiab lawv txawv ntawm dataset, kab zauv ntev, thiab txhais ntawm "chij."
Lub luag hauj lwm tseem yog cov nyiaj tau los-txhim kho thaj tsam ntawm kev tshuaj ntsuam xyuas: nws txuas rau tsoomfwv cov nyiaj txiag tshawb fawb thiab tseemfwv qibsiab kev yuav khoom, tsis yog rau txhua qhov kev lag luam ntiag tug. Cov neeg muag khoom yuav tsum tsis txhob piav txog 50-nt kev tshuaj ntsuam raws li txoj cai dav dav.
Khoom siv Traceability: Ntau Genealogy Los ntawm Synthesis mus rau Kev Xa Khoom
Peptide cov ntaub ntawv traceability tsis yog ib phau ntawv ntawm PDFs. Nws yog ntau tus lej uas sib haum thoob plaws txhua daim ntawv hauv kev xa khoom, los ntawm raw amino acid input los ntawm synthesis, ua kom huv, analytical tso tawm xeem, ntim thiab thauj zaum kawg.
Cov saw hlau ua haujlwm yog linear, thiab txhua kauj ruam tsim ib daim ntawv uas yuav tsum nqa tib lub cim ntau. Daim ntawv txais khoom nyoos tsim cov ntaub ntawv tshuaj xyuas tuaj. Solid-phase synthesis tsim cov ntaub ntawv batch. Purification thiab counterion pauv, suav nrog TFA-rau-acetate conversion qhov twg daim ntawv thov yuav tsum tau, tsim cov ntaub ntawv analytical hauv txheej txheem. Kev ntsuam xyuas tso tawm tsim cov ntawv pov thawj ntawm kev txheeb xyuas, nrog tus kheej thiab purity tsim los ntawm HPLC thiab LC-MS thiab, qhov twg muaj feem, endotoxin ntsuas los ntawm LAL assay. Ntim thiab xa khoom xa tuaj ua cov ntawv ntim khoom, chain-of-custody record thiab txias-chain pov thawj.
Kev kuaj xyuas yog yooj yim: xaiv ntau tus lej thiab paub meej tias nws tshwm rau ntawm CoA, daim ntawv ntim khoom thiab cov ntaub ntawv kaw-ntawm-tus saib xyuas yam tsis muaj qhov sib txawv lossis hloov pauv. Cov pob ntawv yam tsawg kawg nkaus uas ua rau cov saw hlau hla ciam teb peptide tuaj yeem tshawb xyuas tau khiav los ntawm tus neeg muag khoom tus kheej los ntawm ntau tus lej, CoA phim rau qhov ntau, invoice thiab packing list, daim ntawv txais nyiaj nrog tus tuav lub npe thiab lub sijhawm teev, khaws cia thiab cov ntaub ntawv pov thawj txias, thauj cov ntaub ntawv thiab txoj kev, import cov ntaub ntawv, thiab QA tso tawm kos npe tawm. Regulator-qib cov ntaub ntawv yuav tsum ua raws li ALCOA cov lus cog tseg: tsim nyog, paub cai, niaj hnub no, thawj thiab yog, nyob rau hauv version tswj.
Cov ntaub ntawv tsis sib xws yog qhov uas qhov no tawg hauv kev xyaum. Ib FDA ceeb toom tsab ntawv tshuaj xyuas rau cov khoom lag luam-kev tsim nyog ua tsis tiav pom API cov qhabnias sib txawv los ntawm tus muag khoom CoA los ntawm 7.8% hauv qee kis, nrog tus neeg muag khoom API tshiab yeej tsis tsim nyog. Ib cais 2025 rooj plaub ua txhaum lub tuam txhab uas nws qhov kev tsim nyog ntawm cov chaw tsim khoom cog lus tau khiav peb xyoos lig.
Traceability kuj muaj qhov tsis pub leej twg paub. Lub moj khaum cov lus qhia txog kev tiv thaiv kab ke databases hauv kev thauj mus los thiab so hu rau cais cov ntsiab lus sib txuas los ntawm cov neeg siv khoom ntiag tug, nrog kev sib txuas tsis pom kev txwv rau ib pawg me me ntawm cov neeg ua haujlwm tau tso cai. Tus neeg muag khoom tus kheej cov lus qhia tshaj tawm feem ntau piav qhia txog cov txheej txheem tshuaj xyuas thiab cov ntaub ntawv kos duab uas nws txhawb nqa, uas yog txoj hauv kev nruab nrab los hais txog lub peev xwm: nws pab tus neeg yuav khoom pom dab tsi tuaj txog nrog ntau ntau ua ntej cog lus rau cov ntaub ntawv tsim nyog.
Export, Shipping thiab Cov ntaub ntawv hla ciam teb
Peptide export thiab shipping cov ntaub ntawv yog ib feem ntawm cov ntaub ntawv tsim nyog, tsis yog ib txoj haujlwm logistics cais, vim peptide cov ntaub ntawv thiab cov cuab yeej nyob ib ncig ntawm lawv tam sim no zaum hauv dual-siv export regimes. Ob txoj kev tswj hwm tau sib txawv ntawm qhov lawv tau mus txog ntawd. EU lub Cuaj Hlis 2025 dual-siv daim ntawv hloov tshiab, tau txais los ntawm Delegated Regulation hloov kho Annex I of Regulation (EU) 2021/821, tshiab ntxiv peptide synthesiss nrog rau quantum, semiconductor, advanced-computing thiab additive-manufacturing khoom (European Commission DG Kev Lag Luam, 8 Cuaj hlis 2025). Txoj kev US txawv: BIS txoj cai siv Australia Pawg tswj hwm ntawm automated peptide synthesis instruments tau siv rau 23 Kaum Ob Hlis 2024, khi txoj kev tswj hwm rau Australia Group daim ntawv teev cov cuab yeej es tsis yog rau kev hloov kho dual-siv dav (ST&R luam ntawv, siv tau 23 Kaum Ob Hlis 2024). Ob leeg yog cov tswj-daim ntawv ntxiv uas yuav tsum tau muaj ntawv tso cai, tsis txwv, thiab tus neeg muag khoom uas tsuas kuaj ib qho kev txiav txim siab yuav txiav txim siab rau lwm tus.
Qhov kev sib txawv ntawd tseem ceeb vim tias kev faib tawm hla ciam teb yog qhov teeb meem peb feem hauv kev hla ciam teb peptide shipping: cov khoom siv lub cev, cov khoom siv, thiab cov ntaub ntawv qhia txog kev ua haujlwm lossis cov ntaub ntawv sib lawv liag cais cais. Cov ntaub ntawv tuav pov hwm, end-use thiab end-user nqe lus, thiab daim ntawv txiav txim xyuas seb qhov kev txiav txim ua rau muaj daim ntawv tso cai yuav tsum muaj nyob rau hauv cov ntaub ntawv.
Rau Tip: cais cov khoom, cov khoom siv thiab cov ntaub ntawv sib txuas ua ke lossis kev paub txog kev sib txuas sib cais, vim tias kev xa tawm cov ntaub ntawv sib txuas lossis cov txheej txheem tuaj yeem ua rau kev hloov pauv ntawm thev naus laus zis.
Tsim Daim Ntawv Pov Thawj: Cov Ntaub Ntawv-by-Document Standard
Cov ntaub ntawv pov thawj peptide tus neeg muag khoom tsim nyog yog cov ntaub ntawv teev tseg, tsis yog ib phau ntawv ntawm PDFs. Lub ntsiab lus rov tshwm sim hauv FDA cov khoom lag luam-kev tshawb pom muaj txiaj ntsig yog cov ntaub ntawv sib txawv: cov ntaub ntawv uas ploj lawm, cov ntaub ntawv tsis tiav, los yog cov ntaub ntawv uas tsis phim cov ntaub ntawv uas lawv piav. Tsim cov ntaub ntawv nyob ib ncig ntawm plaub theem, thiab xav kom txhua cov ntaub ntawv kom ciaj sia tib qhov kev sim: nws puas npe ntau, hnub tim, txoj kev, thiab tus neeg lav ris?
Theem 1: Kev tshuaj ntsuam xyuas ua ntej. Ua ntej tej qauv nkoj, sau cov chaw sau npe thiab tus nqi sawv cev, cov ntawv pov thawj zoo, thiab sau specification hauv paus. Tshawb xyuas txhua qhov tawm tsam tus neeg muab ntawv tso cai ntawm tus kheej sau npe tsis yog tus neeg muag khoom daim ntawv luam.
Theem 2: Kev tshuaj xyuas cov ntaub ntawv. Cov ntaub ntawv teeb tsa uas ua rau kev xa khoom tuaj yeem kuaj tau suav nrog daim ntawv pov thawj ntawm kev tshuaj xyuas (CoA), daim ntawv qhia kev nyab xeeb (SDS/MSDS), specification hauv paus, batch cov ntaub ntawv, export thiab siv cov ntaub ntawv kawg, thiab daim ntawv pov thawj ntawm kev saib xyuas. Rau txhua tus, paub meej tias tus lej ntau phim cov khoom xa tuaj, cov txheej txheem xeem muaj npe, thiab cov txiaj ntsig tau muaj hnub thiab ib tus neeg lav ris kos npe.
Theem 3: Sample thiab batch pov thawj. Ntsuam xyuas cov khoom tau txais los ntawm lub hauv paus specification, tsis tawm tsam CoA ib leeg. Qhov twg CoA tshaj tawm cov duab purity, paub meej cov txheej txheem analytical qab nws.
Theem 4: Kev saib xyuas tsis tu ncua. Rov xyuas dua ntawm lub sijhawm teem tseg, tsis yog ib zaug ntawm onboarding. Ib tus neeg muag khoom tsim nyog tau txais ob xyoos dhau los thiab tsis tau rov kuaj xyuas yog tus neeg muag khoom tsis tau lees paub.
⚠️ Ceeb toom: Lub hauv paus tshwj xeeb uas hloov ntawm kev txiav txim yog tus chij liab txawm tias txhua tus neeg CoA zoo li ua tiav.
Liab Khw chij
Qhov twg nws tshwm
Pov thawj kauj ruam uas catches nws
Cov lej tsis sib xws
CoA, batch ntaub ntawv, Synthetic Peptides chain-of-cause
Hla-check tus lej ntau hla tag nrho peb cov ntaub ntawv ua ntej tso tawm
Undated los yog template CoAs Peptide Production
Daim ntawv pov thawj ntawm kev soj ntsuam
Txheeb xyuas hnub kawg thiab tus neeg kos npe kos npe rau ntawm txhua CoA
Specification hauv paus hloov ntawm kev txiav txim
Specification hauv paus, CoA
Sib piv lub hauv paus tau hais nyob rau hauv kev txiav txim sib law liag los ntawm tib tus neeg muag khoom
Split-order patterns
Kev yuav khoom, shipping cov ntaub ntawv
Reconcile tag nrho cov xaj kom muaj nuj nqis tiv thaiv cov lej ntawm cov khoom xa tuaj
Cov ntaub ntawv khaws cia yog ib qho chaw uas qhov kev taw qhia tsis sib haum. Tsoomfwv Meskas yav dhau los cov lus qhia txog kev tshuaj ntsuam xyuas nucleic-acid pom zoo kom khaws cov ntawv theej hluav taws xob ntawm cov neeg siv khoom xaj uas muaj cov kev txhawj xeeb tsawg kawg yim xyoo., thaum lub hauv paus ntsiab lus sib cais nyob rau hauv tus kws kho mob txheej cites ib tug peb-xyoo daim duab. Txog thaum qhov sib txawv ntawd kaw, khaws cia rau lub sijhawm ntev dua thiab cov ntaub ntawv uas koj tau thov.
Advanced: Tshawb nrhiav kev sib faib kev txiav txim thiab kuaj qhov khoob
Yog hais tias koj twb khiav cov neeg muag khoom kuaj xyuas, qhov kev pheej hmoo seem nyob hauv qhov chaw koj qhov kev tshuaj ntsuam xyuas yuav tsis pom. Qhov kev soj ntsuam nyuaj tshaj plaws tsis yog tsis yog ib qho kev qhia ua ntu zus. Nws yog ib tug faib: tib tus neeg yuav khoom tso qhov kev txiav txim me me hla ntau tus neeg muab kev pabcuam, txhua qhov kev txiav txim me me kom dhau, tsis muaj leej twg pom rau ib tus neeg muag khoom.
Cov qauv kev faib tawm ntawd yog raws nraim li qhov kev txiav txim kom pom kev sib cais hauv S.3741 yog tsim los kom ncav cuag, thiab nws ua li ntawd los ntawm kev ceev ntiag tug-preserving xa ntawv es tsis yog los ntawm qhov yuav tsum tau qhia tawm. Qhov kev xaiv tsim nthuav tawm qhov nro ntawm kev sib cais-kev txiav txim kom pom thiab cov neeg siv khoom tsis pub lwm tus paub: qhov ntau dua ib qho system tuaj yeem rov tsim kho tus neeg yuav khoom hneev taw hla cov chaw muab kev pabcuam, qhov ntau nws kuj tuav lag luam rhiab cov ntaub ntawv xaj. EBRC cov 2025 kev koom tes nrog cov neeg koom tes, luam tawm nyob rau lub Ib Hlis 2025 raws li Ua kom muaj kev nyab xeeb thiab ruaj ntseg Nucleic Acid Synthesis Ecosystem: Cov txiaj ntsig ntawm EBRC Stakeholder Engagement, hais txog qhov kev ntxhov siab los ntawm cov lus pom zoo ntawm cov neeg siv khoom raug cai, qhia, khaws cia, thiab kev tiv thaiv database hauv kev thauj mus los thiab so. Cov lus pom zoo nthuav dav nyob hauv qhov txuas PDF tsis yog ntawm nplooj ntawv tsaws, thiab tsis tau nyeem no khiav.
Kev ruaj ntseg cov ntaub ntawv ib ntus yog qhov kev qhuab qhia hauv qab no, thiab nws tsuas yog ua haujlwm thaum muaj ob qhov yuav tsum tau ua ua ntej: cov ntaub ntawv ntau-theem sib xws thiab lub qhov rai tshuaj ntsuam xyuas. Tsis muaj ob leeg, split-order detection tsis muaj dab tsi los piv rau.
Pib pib
Pib nrog ib qho khoom xa tuaj. Rub cov khoom xa tuaj tsis ntev los no thiab rov ua kom tus lej ntau hla peb cov ntaub ntawv: daim ntawv pov thawj ntawm kev txheeb xyuas, daim ntawv ntim khoom, thiab daim ntawv pov thawj ntawm kev saib xyuas. Qhov no yog qhov kev ntsuam xyuas ntau tus lej, thiab nws yuav siv li tsib feeb. Yog tias peb tus lej sib phim thiab cov ntaub ntawv kaw-ntawm-tus saib xyuas muaj nyob txhua, koj muaj cov ntaub ntawv traceability. Yog tias ib qho ntawm lawv ploj lawm lossis cov lej sib txawv, koj muaj qhov sib txawv uas yuav tshwm sim thawj zaug tus neeg saib xyuas kev yuav khoom lossis tus kws tshuaj xyuas nug txog nws.
Tom ntej no, thov koj tus neeg muag khoom lub hauv paus ntsiab lus thiab xyuas seb nws puas nyob ruaj khov nyob rau peb qhov kawg. Ib qho tshwj xeeb uas hloov ntawm kev xa khoom, seb nyob rau hauv qib purity, txoj kev analytical, los yog kev lees txais, qhia rau koj tias tus neeg muag khoom tau tso tawm tawm tsam lub hom phiaj txav es tsis yog tus qauv ruaj khov. Nug rau cov ntaub ntawv specification nws tus kheej, tsis yog cov ntsiab lus ntawm nws, thiab sib piv cov txheej txheem hais tawm tsam qhov CoA tau tshaj tawm.
Tom qab ntawd daim ntawv qhia koj tus kheej daim ntawv xaj tawm tsam lub Kaum Hli 13, 2026 tshuaj ntsuam qhov rai. Txheeb xyuas seb cov kab ke twg poob rau hauv 50-nucleotide pib thiab seb koj tus neeg muab khoom puas tuaj yeem ua pov thawj kev tshuaj xyuas ntawm qhov kev daws teeb meem ntawd. Cov ntaub ntawv no tsim tawm yog cov pov thawj tib yam uas tus neeg saib xyuas kev yuav khoom yuav nug rau qhov twg, yog li kev ua haujlwm tsis yog overhead txheej rau saum cov khoom siv. Nws yog cov ntaub ntawv thov, ua ke ntxov.
Cov lus nug nquag
Dab tsi yog peptide tus neeg muab khoom tsim nyog tau txais txiaj ntsig tiag tiag hauv 2026?
Nws xav tau cov ntaub ntawv tshawb xyuas uas ua pov thawj tias tus kheej, kev huv, traceability thiab kev cai tsim khoom, tsis yog daim ntawv pov thawj ib leeg. Hauv kev xyaum, txhais tau hais tias ib qho kev qhia tshwj xeeb nrog cov txheej txheem analytical, ntau cov ntaub ntawv xeem, ib tug ntaub ntawv saw ntawm kev saib xyuas los ntawm synthesis mus rau, thiab tshuaj ntsuam cov ntaub ntawv rau qhov sib lawv liag thiab tus neeg sib tw.
Puas FDA tus nqi siv qhia kuv txhua yam txog tus neeg muag khoom cov khoom zoo?
Tsis muaj. Tus neeg siv cov nqi them rau kev tshuaj xyuas daim ntawv thov tshuaj, tsis yog kev tsim khoom lossis kev sim ntawm cov khoom nws tus kheej, yog li daim ntawv them nqi yog pov thawj ntawm kev ua ntaub ntawv, tsis yog purity los yog tus kheej. Kho nws ua ib qho kev tswj xyuas cov ntaub ntawv taw qhia thiab txheeb xyuas qhov zoo los ntawm kev txheeb xyuas cov ntaub ntawv hloov pauv.
Dab tsi hloov thaum Lub Kaum Hli 13, 2026?
Qhov kev tshuaj ntsuam xyuas rau cov neeg sib tw thiab cov kev sib tw ua ke yuav nqaim rau hnub ntawd, uas txhais tau hais tias cov neeg xa khoom yuav tsum tau khiav cov tshev ua ntej ntawm lub voj voog xaj ntau dua li ntawm kev xa khoom. Cov neeg yuav khoom yuav tsum nug thaum twg hauv lawv cov haujlwm ua haujlwm txhua daim tshev tshwm sim, tsis yog seb nws tshwm sim.
Puas yog BIOSECURE Txoj Cai Lij Choj lossis tseem tau thov?
Qhov kev sib txawv ntawm kev sib txawv-vim-them teeb meem ntawm no: Cov kev cai tau tsim nyob rau hauv FY2026 NDAA, thaum lub standalone S.3741 tsis tau raug cai. Vim hais tias cov ntawv enacted nyob rau ntawm ib qho chaw hauv qhov kev tshuaj xyuas no, lees paub cov lus tam sim no ua ntej koj hais hauv daim ntawv cog lus.
Ua peptide synthesisers tam sim no xav tau kev tso cai xa tawm?
Hauv qee qhov kev txiav txim, yog. Tebchaws Asmeskas thiab EU tswj-cov npe ntxiv sib txawv, yog li ib tug synthesizer cleared rau export nyob rau hauv ib tug tsoom fwv kuj tseem xav tau kev tso cai nyob rau hauv lwm yam. Nug koj tus neeg muag khoom uas tswj cov npe lawv tau tshuaj xyuas thiab rau qhov chaw twg.
Kuv tuaj yeem tshawb xyuas qhov kev txiav txim cais li cas?
Kev txiav txim sib cais tshwm sim raws li ntau yam khoom xa tuaj uas ib tus zuj zus poob rau hauv qhov kev tshuaj ntsuam tab sis ua ke tshaj nws. Qhov kev txiav txim kom paub txog kev sib cais hauv S.3741 lub hom phiaj raws nraim qhov qauv no, yog li reconcile cov khoom xa tuaj ntim tawm tsam thawj qhov kev txiav txim es tsis yog tshuaj xyuas txhua qhov kev xa khoom hauv kev sib cais.
Dab tsi yuav tsum tau ua raws li CoA muaj?
Daim ntawv pov thawj raws li kev txheeb xyuas npe ntau, cov kev xeem, ntsuas cov txiaj ntsig nrog units, cov kev txwv tshwj xeeb, lub chaw kuaj mob, thiab hnub tsom xam. Cov kev cai CoA nyob rau hauv ib pob ntawv soj ntsuam kuj cia siab tias daim ntawv pov thawj yuav traceable rau tib tus lej ntau uas tshwm rau ntawm daim ntawv xa khoom..
Xaus
The new burden of proof in peptide supplier qualification is documentary and auditable. A supplier that cannot produce the paperwork behind a lot cannot defend the lot, no matter how strong its technical capability looks on a call.
The six layers covered in this guide are one program, not four compliance topics. User-fee status, biosecurity screening, lot genealogy, and cross-border records all feed a single qualification file, and a gap in any one of them weakens the whole. Three dates now set the pace: the September 30, 2027 expiry of the current FDA user-fee authority, the October 13, 2026 tshuaj ntsuam qhov rai, and the regulations S.3741 would set in motion once Congress acts.
Start with the document-by-document standard, build the file before you need it, and re-screen suppliers on a fixed cycle rather than at renewal.
Yog tias koj xav ua haujlwm los ntawm daim ntawv teev npe npaj ntau dua li tsim ib qho los ntawm kos, tham nrog tus kws tshaj lij lossis thov kom muaj peev xwm pob khoom. Txog
Qhia tawm: MOL Hloov muaj kev lag luam txaus siab rau cov qauv zoo peptide thiab cov ntaub ntawv muab khoom siv.
